Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: PK who wrote (948)	5/11/1998 11:28:00 AM
From: TokyoMex	Read Replies (1) \| Respond to of 2135

Took out 34 1/2 ,,, on 2000 ,, ;-)

To: PK who wrote (948)	5/11/1998 2:33:00 PM
From: Jeffrey S. Mitchell	Respond to of 2135

Re: A portfolio of Angiogenesis stocks I compiled the following list of stocks having something to do with Angiogenesis. As I'm not an expert on the subject I assembled the list from material I saw, among other places, posted on this thread. I "purchased" enough shares for each company to simulate a $10,000 investment as of the close of 5/1/98, the last trading day before the ENMD article hit. Except for ENMD and the pennies, the list is relatively unimpressive, IMO. Is the prevailing wisdom here that these other stocks have EMND-like potential on any given day? The portfolio: techstocks.com - Jeff